Category Archives: Uncategorized @en

Inadequate safety reporting in the publications of randomised clinical trials in irritablebowel syndrome: drug versus probiotic interventions

Inadequate safety reporting in the publications of randomised clinical trials in irritablebowel syndrome: drug versus probiotic interventions A.M. van der Geest1*, I. Schukking1, R.J.M. Brummer2, H. Pieterse3, M. van den Nieuwboer4, L.H.M. van deBurgwal1 and O.F.A. Larsen Vrije Universiteit Amsterdam, Athena Institute, De Boelelaan 1085, 1081 HV Amsterdam, the Netherlands; 2Nutrition-Gut-Brain Interactions Research Centre, School… Continue Reading

Towards a Global Implementation of eConsent in Clinical Trials.

Towards a Global Implementation of eConsent in Clinical Trials. Lou Guffroy*, Herman Pieterse**, David Fauvart***, Yves Geysels**** Applied Clinical Trials 2022, June 28. * NBCD  A/S,  Herlev,  Denmark  &  Paris,  France. ** University of Ghent, Heymans Institute for Pharmacology, Ghent, Belgium and Profess Medical Consultancy B.V. in Heerhugowaard, The Netherlands *** Janssen Pharmaceutica NV –… Continue Reading

Quality in Nuclear Medicine

In deel 1 van het handboek “Quality in Nuclear Medicine” heeft Prof. Dr. Herman Pieterse samen met Prof. Dr. Jan Pruim een uitgebreid hoofdstuk geschreven over Good Clinical Practices in (Nuclear) Research. In 36 pagina’s komen alle aspecten aan bod. Saillant te noemen is de vertaling van de regels naar de dagelijkse praktijk van klinisch… Continue Reading